Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Euronext Alternext  >  Neovacs    ALNEV   FR0004032746

NEOVACS (ALNEV)

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
07/22/2015 07/23/2015 07/24/2015 07/27/2015 07/28/2015 Date
1.06(c) 1.05(c) 1.03(c) 1.05(c) 1.05 Last
260 322 171 709 170 649 120 709 146 385 Volume
-3.64% -0.94% -1.90% +1.94% 0.00% Change
More quotes
Financials (€)
Sales 2015 5,03 M
EBIT 2015 -5,58 M
Net income 2015 -6,45 M
Debt 2015 1,06 M
Yield 2015 -
Sales 2016 0,05 M
EBIT 2016 -10,2 M
Net income 2016 -6,33 M
Debt 2016 8,35 M
Yield 2016 31,7%
PER 2015 -
PER 2016
EV / Sales 2015 6,91x
EV / Sales 2016 840x
Capitalization 33,7 M
More Financials
Company
Neovacs SA is a biotechnology company which engages in the development of active immunotherapies for treating auto-immune, inflammatory, and cancerous diseases.It focuses on the development of Tumor Necrosis Factor-Kinoid for treating Crohn's disease and rheumatoid polyarthritis, and... 
More about the company
Surperformance© ratings of Neovacs
Trading Rating : Investor Rating :
More Ratings
Latest news on NEOVACS
07/03 NEOVACS : ANNOUNCES CLOSING OF 7.5M EURO CAPITAL INCREASE WITH U.S. INSTITUTIONA..
07/03 NEOVACS : half-year report on the liquidity contract
07/02 NEOVACS : ANNOUNCES CLOSING OF 7.5M EURO CAPITAL INCREASE WITH U.S. INSTITUTIONA..
07/02 NEOVACS : raises 7.5 million euros in capital increase with U.S. investors
07/02 NEOVACS : announces closing of 7.5 M Euro capital increase with U.S. investors
06/29 NEOVACS : Announces to Raise USD8.4 Million in Private placement of Shares
06/27 NEOVACS : RAISES 7.5 MILLION EUROS IN CAPITAL INCREASE WITH U.S. INSTITUTIONAL I..
06/26 NEOVACS : RAISES 7.5 MILLION EUROS IN CAPITAL INCREASE WITH U.S. INSTITUTIONAL I..
More news
Sector news : Biotechnology & Medical Research - NEC
04:06p INTREXON : Oragenics Reports Positive In Vivo Antibiotic Efficacy Data in Critic..
07:01a ISIS PHARMACEUTICALS' : Second Quarter 2015 Financial Results Conference Call (W..
06:18a UNITED THERAPEUTICS : beats 2Q profit forecasts
More sector news : Biotechnology & Medical Research - NEC


Comments 
Advertisement
Chart NEOVACS
Duration : Period :
Neovacs Technical Analysis Chart | ALNEV | FR0004032746 | 4-Traders
Full-screen chart
Technical analysis trends NEOVACS
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions